Skip to Content

Mar 2013

  • Mar202013
    Parkinson’s Patients May Be Harmed by Novel Treatment

    Bloomberg

    The results suggest patients in clinical trials to lower alpha- synuclein may be at risk, said Demetrius Maraganore, a study author... “There is a sense of urgency related to their safety,” Maraganore, who is chairman of neurology at NorthShore...